These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 28295628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Erythropoiesis and erythrocyte age distribution in hemodialysis patients undergoing erythropoietin therapy.
    Hampl H, Riedel E, Scigalla P, Stabell U, Wendel G.
    Blood Purif; 1990; 8(3):117-25. PubMed ID: 2244989
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis.
    Antonelou MH, Kriebardis AG, Velentzas AD, Kokkalis AC, Georgakopoulou SC, Papassideri IS.
    J Proteomics; 2011 Oct 19; 74(11):2441-52. PubMed ID: 21515423
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca.
    Linde T, Ronquist G, Sandhagen B, Wikström B, Frithz G, Pettersson L, Danielson BG.
    Nephron; 1994 Oct 19; 68(4):419-26. PubMed ID: 7870225
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.
    Matsumura M, Hatakeyama S, Koni I, Mabuchi H, Muramoto H.
    Nephron; 1996 Oct 19; 72(4):574-8. PubMed ID: 8730424
    [Abstract] [Full Text] [Related]

  • 12. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H, Heusser K, Höffken B, Huber P, Schmieder RE, Schobel HP.
    Kidney Int; 2004 Aug 19; 66(2):832-40. PubMed ID: 15253740
    [Abstract] [Full Text] [Related]

  • 13. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
    Sachs G, Siems W, Grune T, Schmidt G, Gerber G, Zoellner K.
    Biomed Biochim Acta; 1990 Aug 19; 49(2-3):S123-4. PubMed ID: 2386496
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of circulating erythrocytes from myelodysplastic patients treated with recombinant human erythropoietin.
    Shapiro S, Gershon H, Rosenbaum H, Merchav S.
    Leukemia; 1993 Sep 19; 7(9):1328-33. PubMed ID: 8371583
    [Abstract] [Full Text] [Related]

  • 16. Red blood cell osmotic fragility in chronically hemodialyzed patients.
    Wu SG, Jeng FR, Wei SY, Su CZ, Chung TC, Chang WJ, Chang HW.
    Nephron; 1998 Sep 19; 78(1):28-32. PubMed ID: 9453400
    [Abstract] [Full Text] [Related]

  • 17. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
    Bovy C, Gothot A, Delanaye P, Warling X, Krzesinski JM, Beguin Y.
    Nephrol Dial Transplant; 2007 Apr 19; 22(4):1156-62. PubMed ID: 17237481
    [Abstract] [Full Text] [Related]

  • 18. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT, Lubrano R, Meloni C, Morosetti M, Manca di Villahermosa S, Scoppi P, Palombo G, Castello MA, Casciani CU.
    Clin Nephrol; 1999 Oct 19; 52(4):239-45. PubMed ID: 10543326
    [Abstract] [Full Text] [Related]

  • 19. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P, Ferrant A, Daelemans R, Coolen L, Goossens W, Lins RL, Couttenye M, De Broe ME, Boogaerts MA.
    Nephron; 1993 Oct 19; 65(2):288-93. PubMed ID: 8247195
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients.
    Di Pietro N, Giardinelli A, Sirolli V, Riganti C, Di Tomo P, Gazzano E, Di Silvestre S, Panknin C, Cortese-Krott MM, Csonka C, Kelm M, Ferdinandy P, Bonomini M, Pandolfi A.
    Mol Cell Biochem; 2016 Jun 19; 417(1-2):155-67. PubMed ID: 27206740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.